Aclaris Therapeutics, Inc. Financial Ratios — ACRS Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-53.93	-36.9	-35.59	-32.66	-51.14	-86.32	-60.34	-56.44	-34.36	-39.15	-63.23	-34.1
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	28.28	29.62	4.07	20.81	30.29	59.8	42.14	17.43	6.93
EBITDA Margin (%)	- -	- -	- -	- -	-3,146.7	-1,347.76	-2,020.61	-728.09	-953.42	-283.53	-369.46	-276.28	-940.72
Operating Margin (%)	- -	- -	- -	- -	-3,170.59	-1,378.31	-2,172.23	-748.52	-967.08	-286.21	-372.22	-280.59	-946.52
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	-3,107.01	-1,334.81	-2,686.11	-791.98	-1,343.96	-292.11	-284.32	-705.48	-829.58
Profit Margin (%)	- -	- -	- -	- -	-4,071.48	-2,157.99	-3,817.22	-787.03	-1,343.96	-292.11	-283.15	-705.48	-829.58
Net Income to Common Margin (%)	- -	- -	- -	- -	-4,071.48	-2,157.99	-3,817.22	-787.03	-1,343.96	-292.11	-283.15	-705.48	-829.58
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	24.94	19.43	11.09	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	30	1	11	1	1	- -	- -	- -
ST Debt	- -	- -	- -	- -	- -	- -	1	1	1	1	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	30	- -	11	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	- -	- -	- -	- -	-0.36	-0.01	-0.24	-0.01	-0.01	- -	- -	- -
Net Debt/EBITDA	1.83	1.26	0.48	0.63	0.38	0.33	0.4	0.24	0.42	0.54	0.35	0.48	0.27
Total Debt/EBIT	- -	- -	- -	- -	- -	-0.35	-0.01	-0.23	-0.01	-0.01	- -	- -	- -
Net Debt/EBIT	1.82	1.26	0.48	0.63	0.38	0.32	0.37	0.24	0.42	0.53	0.34	0.47	0.27
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-64.52	-119.4	-45.53	-51.63	-65.47	-106.03	-461.38	-712.79	-237.01	-268	-390.46	-409.78	-603.13
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	13.91	- -	28.29	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	-11.41	- -	-2.16	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	10.86	- -	15.05	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	- -	- -	0.06	13.97	0.91	29.9	0.35	0.35	0.27	- -	- -
Total Debt/Capital (%)	- -	- -	- -	- -	-0.09	-11.47	-0.14	-2.28	-0.12	-0.1	-0.06	- -	- -
Total Debt/Total Assets (%)	- -	- -	- -	- -	0.06	10.91	0.65	15.9	0.28	0.27	0.22	- -	- -
Net Debt to Equity	104.64	51.83	-10.65	-17.8	-8.97	-12.6	-48.9	-30.31	-13.86	-22.91	-25.37	-15.8	-19.36
Net Debt/Capital (%)	51.13	34.14	18.7	24.92	11.25	8.49	7.02	2.21	4.4	6.23	4.92	2.65	2.02
EBITDA	-5	-9	-21	-48	-53	-83	-85	-47	-64	-84	-115	-52	-74
EBITDA-CapEx	-5	-9	-21	-48	-54	-84	-87	-48	-65	-85	-117	-88	-74
Operating Income (Loss)	-5	-9	-21	-48	-53	-85	-92	-49	-65	-85	-116	-53	-74

Liquidity (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	36.31	11.12	54.58	22.05	15.19	6.14	3.27	3.64	8.35	9.92	3.85	3.6	3.17
Current Ratio	36.47	11.26	55.64	22.27	15.69	6.56	3.74	3.87	8.94	10.55	4.16	3.99	3.36
Quick Ratio	36.31	11.12	54.58	22.05	15.23	6.16	3.3	3.69	8.37	9.94	3.86	3.61	3.17
CFO/Avg Current Liab	- -	-8.4	-13.55	-8.9	-5.76	-5.03	-3.88	-2.07	-2.76	-3.01	-2.96	-0.64	-1.56
Common Equity/Total Assets	-64.52	-119.4	-45.53	-51.63	-65.47	-106.03	-461.38	-712.79	-237.01	-268	-390.46	-409.78	-603.13
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	13.91	- -	28.29	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	-11.41	- -	-2.16	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	10.86	- -	15.05	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	- -	- -	0.06	13.97	0.91	29.9	0.35	0.35	0.27	- -	- -
Total Debt/Capital (%)	- -	- -	- -	- -	-0.09	-11.47	-0.14	-2.28	-0.12	-0.1	-0.06	- -	- -
Total Debt/Total Assets (%)	- -	- -	- -	- -	0.06	10.91	0.65	15.9	0.28	0.27	0.22	- -	- -
CFO/Total Liabilities	-21.05	-20.03	-1,309.9	-524.69	-299.57	-166.79	-339.77	-116.6	-96.78	-118.59	-194.71	-30.99	-82.11
CFO/CapEx	- -	-18.31	-40.18	-149.15	-44.26	-74.34	-59.79	-85.28	-169.27	-111.68	-59.84	-0.56	-424.44
Altman's Z-Score	-1.02	-2.26	63.2	52.15	21.99	0.41	-7.79	-7.72	5.81	6.96	-5.57	-4.15	-5.55

Working Capital (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	7	11.78	6.67	8.78	9.69	53.75	79.92	60.78	49.22
Days Sales Outstanding	- -	- -	- -	- -	52.16	30.98	54.7	41.56	37.66	6.79	4.57	6.01	7.42
Inventory Turnover	- -	- -	- -	- -	- -	10.95	10.25	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	33.35	35.6	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	0.23	0.53	0.3	0.68	0.62	1.18	1.88	2.28	0.82
Accounts Payable Turnover Days	- -	- -	- -	- -	1,612.86	694.96	1,207.27	539.39	590.09	310.31	194.09	160.19	447.18
Cash Conversion Cycle	- -	- -	- -	- -	-1,560.71	-630.64	-1,116.97	-497.84	-552.44	-303.52	-189.52	-154.18	-439.76
Inventory to Cash Days	- -	- -	- -	- -	52.16	-2.37	19.1	41.56	37.66	6.79	4.57	6.01	7.42
Inventories	- -	- -	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	165	581	693	243	78	275	825	1,027	73	192	369
- Cash & Cash Equivalents	10	11	10	30	20	57	34	22	27	45	40	25	20
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	30	1	11	1	1	- -	- -	- -
Enterprise Value	-13	-16	80	444	499	105	5	232	634	810	-45	78	278
Total Capital	-9	-21	-43	-91	-159	-262	-453	-493	-595	-682	-770	-903	-968
Total Debt/Capital (%)	- -	- -	- -	- -	-0.09	-11.47	-0.14	-2.28	-0.12	-0.1	-0.06	- -	- -
Total Debt / EV	- -	- -	- -	- -	- -	0.29	0.12	0.05	- -	- -	-0.01	- -	- -
EV/Sales	- -	- -	- -	- -	296.67	17.12	1.3	35.85	93.79	27.23	- -	4.17	35.54
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.93	- -
Diluted Market Cap	- -	- -	165	581	693	243	78	275	825	1,027	73	192	369
Diluted Enterprise Value	-10	-11	155	551	673	216	45	264	798	983	34	167	349
EV per Share	- -	- -	13.04	20.73	17.77	3.2	0.13	5.46	11.18	12.42	- -	1.01	2.27
TTM Sales	- -	- -	- -	- -	2	6	4	6	7	30	31	19	8
TTM EBITDA	-5	-9	-21	-48	-53	-83	-85	-47	-64	-84	-115	-52	-74
TTM Operating Income	-5	-9	-21	-48	-53	-85	-92	-49	-65	-85	-116	-53	-74
TTM Cash Flow to Firm	-5	-8	-20	-35	-55	-101	-96	-39	-52	-68	-78	-20	-47
TTM Free Cash Flow to Firm	-5	-7	-20	-34	-53	-99	-95	-38	-52	-67	-77	16	-47

Multiples (USD)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-8.28	-16.91	-12.97	-2.45	-0.82	-7.21	-15.92	-15.34	-0.95	12.09	-7.85
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-13	-16	80	444	499	105	5	232	634	810	-45	78	278
Low Price	- -	- -	10.99	14.12	21.32	6.15	0.74	0.7	5.65	9.26	0.59	0.86	1.05
EV/Sales	- -	- -	- -	- -	296.67	17.12	1.3	35.85	93.79	27.23	- -	4.17	35.54
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-5.11	-9.54	-10.98	-4.15	-0.96	-1.92	-11.45	-11.17	-6.56	-0.89	-3.66
Price/Earnings High	- -	- -	-8.95	-14.16	-13.64	-6.51	-2.1	-6.63	-18.97	-14.23	-14.63	-3.03	-6.57
Price/Earnings Low	- -	- -	-2.9	-6.29	-8.74	-1.52	-0.19	-0.58	-3.53	-6.95	-0.47	-0.5	-1.98
Price/Book Value	- -	- -	-3.84	-6.39	-4.35	-0.83	-0.17	-0.55	-1.39	-1.51	-0.1	-0.21	-0.38
Price/Book Value Average	- -	- -	-2.76	-5.05	-4.72	-1.89	-0.34	-0.19	-1.75	-1.42	-0.75	-0.13	-0.25
Price/Book Value High	- -	- -	-4.83	-7.49	-5.86	-2.96	-0.75	-0.67	-2.89	-1.81	-1.68	-0.44	-0.44
Price/Book Value Low	- -	- -	-1.57	-3.33	-3.76	-0.69	-0.07	-0.06	-0.54	-0.89	-0.05	-0.07	-0.13
Price/Tangible Book Value	- -	- -	1.78	3.43	3.48	1.28	1.25	9.02	4.33	5.39	0.47	1.23	3.58
Price/Tangible Book Value Average	- -	- -	1.28	2.71	3.77	2.91	2.47	3.21	5.47	5.09	3.7	0.76	2.31
Price/Tangible Book Value High	- -	- -	2.24	4.02	4.69	4.56	5.4	11.08	9.06	6.49	8.25	2.57	4.14
Price/Tangible Book Value Low	- -	- -	0.73	1.78	3	1.07	0.49	0.98	1.68	3.17	0.26	0.43	1.25
Price/Sales	- -	- -	- -	- -	411.77	39.54	18.48	42.46	122	34.52	2.35	10.24	47.14
Price/Sales Average	- -	- -	- -	- -	447.25	89.62	36.65	15.1	153.82	32.63	18.57	6.3	30.39
Price/Sales High	- -	- -	- -	- -	555.2	140.45	80.07	52.17	254.91	41.56	41.42	21.35	54.5
Price/Sales Low	- -	- -	- -	- -	356	32.9	7.23	4.59	47.41	20.3	1.32	3.53	16.44
Price/Cash Flow	- -	- -	-8.08	-16.8	-12.68	-2.41	-0.81	-7.12	-15.82	-15.2	-0.94	-9.55	-7.83
Price/Cash Flow Average	- -	- -	-5.8	-13.26	-13.77	-5.47	-1.61	-2.53	-19.95	-14.37	-7.41	-5.87	-5.05
Price/Cash Flow High	- -	- -	-10.16	-19.68	-17.09	-8.57	-3.51	-8.75	-33.06	-18.3	-16.52	-19.91	-9.05
Price/Cash Flow Low	- -	- -	-3.3	-8.74	-10.96	-2.01	-0.32	-0.77	-6.15	-8.94	-0.53	-3.29	-2.73
Price/Free Cash Flow Average	- -	- -	-5.95	-13.35	-14.09	-5.54	-1.63	-2.56	-20.07	-14.5	-7.54	7.44	-5.06
Price/Free Cash Flow High	- -	- -	-10.42	-19.81	-17.49	-8.69	-3.57	-8.86	-33.26	-18.47	-16.81	25.2	-9.07
Price/Free Cash Flow Low	- -	- -	-3.38	-8.8	-11.21	-2.04	-0.32	-0.78	-6.18	-9.02	-0.53	4.17	-2.74
EV/Sales Average	- -	- -	- -	- -	435.33	85.24	28.71	13.43	149.88	31.13	17.31	4.99	27.84
EV/Sales High	- -	- -	- -	- -	543.28	136.06	72.13	50.51	250.97	40.06	40.16	20.03	51.95
EV/Sales Low	- -	- -	- -	- -	344.08	28.52	- -	2.93	43.47	18.8	0.06	2.22	13.89
EV/EBITDA Average	1.83	1.26	-5.26	-8.9	-13.83	-6.32	-1.42	-1.84	-15.72	-10.98	-4.69	-1.81	-2.96
EV/EBITDA High	1.83	1.26	-9.58	-13.52	-17.27	-10.1	-3.57	-6.94	-26.32	-14.13	-10.87	-7.25	-5.52
EV/EBITDA Low	1.83	1.26	-2.78	-5.65	-10.93	-2.12	0.03	-0.4	-4.56	-6.63	-0.02	-0.8	-1.48
EV/EBIT Average	1.82	1.26	-5.24	-8.88	-13.73	-6.18	-1.32	-1.79	-15.5	-10.88	-4.65	-1.78	-2.94
EV/EBIT High	1.82	1.26	-9.53	-13.48	-17.14	-9.87	-3.32	-6.75	-25.95	-14	-10.79	-7.14	-5.49
EV/EBIT Low	1.82	1.26	-2.77	-5.64	-10.85	-2.07	0.03	-0.39	-4.49	-6.57	-0.02	-0.79	-1.47
Last Price	- -	- -	26.94	27.14	24.66	7.39	1.89	6.47	14.54	15.75	1.05	2.48	3.01
High Price	- -	- -	33.88	31.8	33.25	26.25	8.19	7.95	30.38	18.96	18.54	5.17	3.48
Enterprise Value Average	-10	-11	108	429	733	524	121	87	1,013	926	541	93	218
Enterprise Value High	-10	-11	197	651	914	837	305	327	1,697	1,192	1,255	375	407
Enterprise Value Low	-10	-11	57	272	579	175	-3	19	294	559	2	42	109

Shares Outstanding	19	19	20	26	31	41	41	45	61	67	71	108	120
Diluted Weighted Avg Shares	11	11	6	21	28	33	41	43	57	65	70	77	123
Basic Weighted Avg Shares	11	11	6	21	28	33	41	43	57	65	70	77	123
Revenue per Share	- -	- -	- -	- -	0.06	0.19	0.1	0.15	0.12	0.46	0.45	0.24	0.06
EBITDA per Share	-0.49	-0.8	-3.37	-2.25	-1.88	-2.52	-2.07	-1.11	-1.14	-1.29	-1.65	-0.67	-0.6
Operating Income per Share	-0.49	-0.8	-3.38	-2.25	-1.9	-2.58	-2.22	-1.14	-1.15	-1.31	-1.67	-0.68	-0.6
Basic EPS, GAAP	-0.65	-0.99	-3.79	-2.25	-2.44	-4.03	-3.9	-1.2	-1.6	-1.33	-1.27	-1.71	-0.53
Basic EPS from Cont Ops	-0.49	-0.8	-3.37	-2.25	-1.8	-2.49	-2.75	-1.2	-1.6	-1.33	-1.27	-1.71	-0.53
Diluted EPS, GAAP	-0.65	-0.99	-3.79	-2.25	-2.44	-4.03	-3.9	-1.2	-1.6	-1.33	-1.27	-1.71	-0.53
Diluted EPS from Cont Ops	-0.49	-0.8	-3.37	-2.25	-1.8	-2.49	-2.75	-1.2	-1.6	-1.33	-1.27	-1.71	-0.53
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.46	-0.72	-3.34	-1.62	-1.95	-3.06	-2.33	-0.91	-0.92	-1.04	-1.12	-0.26	-0.38
Free Cash Flow per Basic Share	-0.46	-0.76	-3.42	-1.63	-1.99	-3.1	-2.37	-0.92	-0.92	-1.05	-1.14	-0.72	-0.39
Cash & Equivalents per Share	1.25	1.51	13.9	6.41	6.9	5.1	1.77	1.27	3.37	3.34	1.71	1.47	0.74
Book Value per Share	-0.86	-1.95	-7.01	-4.25	-5.67	-8.88	-10.97	-11.86	-10.5	-10.46	-11.04	-11.68	-7.9
Tangible Book Value per Share	-0.86	-1.95	15.15	7.91	7.1	5.75	1.52	0.72	3.35	2.92	2.25	2.01	0.84

Aclaris Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)